InvestorsObserver
×
News Home

Is ACADIA Pharmaceuticals Inc. (ACAD) a Stock to Watch After Gaining 13.49% This Week?

Wednesday, December 08, 2021 10:57 AM | InvestorsObserver Analysts

Mentioned in this article

Is ACADIA Pharmaceuticals Inc. (ACAD) a Stock to Watch After Gaining 13.49% This Week?

The market has been high on ACADIA Pharmaceuticals Inc. (ACAD) stock recently. ACAD gets a Bullish score from InvestorsObserver Stock Sentiment Indicator.

Sentiment Score - ,bullish
ACADIA Pharmaceuticals Inc. has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on ACAD!

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score. As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With ACAD Stock Today?

ACADIA Pharmaceuticals Inc. (ACAD) stock is up 0.61% while the S&P 500 is lower by -0.08% as of 10:47 AM on Wednesday, Dec 8. ACAD has risen $0.13 from the previous closing price of $21.32 on volume of 212,963 shares. Over the past year the S&P 500 is higher by 26.84% while ACAD is lower by -59.82%. ACAD lost -$1.20 per share in the over the last 12 months.

More About ACADIA Pharmaceuticals Inc.

Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology. Click Here to get the full Stock Report for ACADIA Pharmaceuticals Inc. stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App